The Appropriate Level of Continuous Adductor Canal Block in Patients Undergoing Total Knee Arthroplasty (TKA)

October 7, 2021 updated by: Yonsei University
Adductor canal catheters are being used to provide continuous postoperative analgesia after total knee arthroplasty surgery (TKA). There is much debate about where is the best position of continuous adductor canal block in patients undergoing TKA. Therefore, the investigators aim to compare the postoperative pain at three different level of continuous adductor canal block. Ninety six patients scheduled for total knee arthroplasty will be randomly divided into the three groups. In group 1, the adductor canal catheter is inserted at femoral triangle apex (the proximal end of the adductor canal). In group 2, the adductor canal catheter is inserted femur length/15*2 cm above the location where the nerve block performed in group 1. In group 3, the adductor canal catheter is inserted femur length/15cm below the location where the nerve block performed in group 1.

Study Overview

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 03722
        • Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1. Patients undergoing total knee arthroplasty

Exclusion Criteria:

  • 1. Patients who have infection or had surgery on the thigh
  • 2. The subject is a foreigner or illiterate
  • 3. Patients who have cognitive dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Group 1(femoral triangle apex)
the adductor canal catheter is inserted at femoral triangle apex (the proximal end of the adductor canal)
In group 1, the adductor canal catheter is inserted at femoral triangle apex (the proximal end of the adductor canal).
ACTIVE_COMPARATOR: Group 2(femur length/15*2 cm above)
the adductor canal catheter is inserted femur length/15*2 cm above the location where the nerve block performed in group 1
In group 2, the adductor canal catheter is inserted femur length/15*2 cm above the location where the nerve block performed in group 1.
ACTIVE_COMPARATOR: Group 3(femur length/15 cm below)
the adductor canal catheter is inserted femur length/15cm below the location where the nerve block performed in group 1.
In group 3, the adductor canal catheter is inserted femur length/15 cm below the location where the nerve block performed in group 1.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain : Visual Analogue Scale (VAS) for pain
Time Frame: Baseline (Before surgery)
The visual analog scale(VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (0) and "worst pain." (10). The ends are defined as the extreme limits of the parameter to be measured(symptom,pain,health) orientated from the left(0, worst) to the right(10, best).
Baseline (Before surgery)
Pain : Visual Analogue Scale (VAS) for pain
Time Frame: postoperative day 1
The visual analog scale(VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (0) and "worst pain." (10). The ends are defined as the extreme limits of the parameter to be measured(symptom,pain,health) orientated from the left(0, worst) to the right(10, best).
postoperative day 1
Pain : Visual Analogue Scale (VAS) for pain
Time Frame: postoperative day 2
The visual analog scale(VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" (0) and "worst pain." (10). The ends are defined as the extreme limits of the parameter to be measured(symptom,pain,health) orientated from the left(0, worst) to the right(10, best).
postoperative day 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
muscle strength
Time Frame: Baseline (Before surgery)
Quadriceps strength of both legs was assessed by placing the dynamometer on the anterior of the ankle, between the malleoli.
Baseline (Before surgery)
muscle strength
Time Frame: postoperative day 1
Quadriceps strength of both legs was assessed by placing the dynamometer on the anterior of the ankle, between the malleoli.
postoperative day 1
muscle strength
Time Frame: postoperative day 2
Quadriceps strength of both legs was assessed by placing the dynamometer on the anterior of the ankle, between the malleoli.
postoperative day 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 2, 2020

Primary Completion (ACTUAL)

July 16, 2021

Study Completion (ACTUAL)

July 17, 2021

Study Registration Dates

First Submitted

December 17, 2019

First Submitted That Met QC Criteria

December 19, 2019

First Posted (ACTUAL)

December 20, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 15, 2021

Last Update Submitted That Met QC Criteria

October 7, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 4-2019-1038

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Degenerative Arthritis

Clinical Trials on the three different sites of continous adductor canal block: the adductor canal catheter is inserted at femoral triangle apex

3
Subscribe